Pantoprazol Aurobindo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurobindo, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Erosive esophagitis: supports mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fracture risk: especially with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output.

When prescribing Pantoprazol Aurobindo, consider patient‑specific factors and monitor for potential complications. - Renal impairment: adjust monitoring, no dose change required. - Hepatic impairment: use with caution, monitor liver function. - Long‑term therapy: assess need periodically to avoid bone density loss. - Concomitant NSAIDs or steroids: increase risk of gastrointestinal bleeding. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: slight increase in serum levels. - Methotrexate (high dose): reduced renal clearance, monitor toxicity. - Iron supplements: decreased iron absorption, separate dosing times.